Symposium Co-Chairs
Jeffrey S. Weber, MD, PhD
Director, Donald A. Adam
Comprehensive Melanoma Research Center
Senior Member, Moffitt Cancer Center
Professor and Associate Chair,
Department of Oncologic Sciences
University of South Florida
Tampa, FL
Alexander M. M. Eggermont, MD, PhD
Department of Surgical Oncology
Erasmus University Medical Center - Daniel den Hoed Cancer Center
Rotterdam, The Netherlands
EORTC Melanoma Group
Brussels, Belgium
F. Stephen Hodi, MD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
Jedd D. Wolchok, MD, PhD
Memorial Sloan-Kettering Cancer Center
Director, Immunotherapy Clinical Trials
Associate Attending Physician, Melanoma-Sarcoma Oncology Service
Associate Director, Ludwig Center for Cancer Immunotherapy
Associate Professor of Medicine, Weill Medical College of Cornell University
|
|
The Next Generation of Therapy for Managing Melanoma Patients: CTLA-4 Blockade, Questions, Clinical Recommendations, and Clinical Cases
|
|
PLEASE NOTE:
Pre-registration is now available on a "stand-by" basis only. We have received the maximum number of 500 confirmed pre-registrants. We do expect that approximately 50 pre-registrants will not attend. So if you are interested in attending this symposium please register now as a "stand-by" pre-registrant. At 6:30PM on June 6, 2010 "standy-by" registrants can attend the symposium on a first-come basis. Thank you.
June 6, 2010 | Chicago IL
Hyatt Regency McCormick Place
Regency Ballroom Second Floor
6 PM - 6:30PM Registration and Dinner
6:30PM - 8:30PM CME Symposium
Taught by the top academic experts in melanoma this is THE symposium on melanoma that you should attend in 2010.
|
 |
CO-CHAIRS
Jeffrey S. Weber, MD, PhD
Director, Donald A. Adam
Comprehensive Melanoma Research Center
Senior Member, Moffitt Cancer Center
Professor and Associate Chair,
Department of Oncologic Sciences
University of South Florida
Tampa, FL
Alexander M. M. Eggermont, MD, PhD
Department of Surgical Oncology
Erasmus University Medical Center - Daniel den Hoed Cancer Center
Rotterdam, The Netherlands
EORTC Melanoma Group
Brussels, Belgium
|
|
|
|
|
|
|
|
Alexander M. M. Eggermont, MD, PhD
Department of Surgical Oncology
Erasmus University Medical Center - Daniel den Hoed Cancer Center
Rotterdam, The Netherlands
EORTC Melanoma Group
Brussels, Belgium
|
|
Jeffrey S. Weber, MD, PhD
Director, Donald A. Adam
Comprehensive Melanoma Research Center
Senior Member, Moffitt Cancer Center
Professor and Associate Chair,
Department of Oncologic Sciences
University of South Florida
Tampa, FL
|
|
F. Stephen Hodi, MD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA
|
|
Jedd D. Wolchok, MD, PhD
Memorial Sloan-Kettering Cancer Center
Director, Immunotherapy Clinical Trials
Associate Attending Physician, Melanoma-Sarcoma Oncology Service
Associate Director, Ludwig Center for Cancer Immunotherapy
Associate Professor of Medicine, Weill Medical College of Cornell University
|
|
|
| Educational Grants |
Sincere appreciation is extended to Bristol-Myers Squibb for their generous commercial support of this educational meeting. |
|
|
|
